David Keire
David Keire is acting laboratory chief, Branch I, Division of Pharmaceutical Analysis, FDA
Articles
Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?
Anita Szajek;Elaine Gray;David Keire;Barbara Mulloy;Ali Al-Hakim;Christina Chase;Monica Da Luz Carvalho Soares;Damian Cairatti;John Hogwood;Paulo Mourão;Tina S. Morris, PhD
November 2nd 2015The global supply chain for bovine and porcine heparin and regulatory considerations are examined.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: February 23rd 2024 | Updated: December 22nd 2024
Europa Perspectives: Helping to Navigate the Regulatory System
Published: December 13th 2024 | Updated: December 22nd 2024
FDA Creates CDER Center for Real-World Evidence Innovation
Published: December 5th 2024 | Updated: December 22nd 2024
Leveraging Advancements in Bioanalytical Testing
Published: December 7th 2024 | Updated: December 22nd 2024
Exploring Opportunities for LNP Delivery in mRNA
